Osteosarcoma in a patient with xeroderma pigmentosum.
Sébastien
S
Ottaviani
Anne
A
Forest
Vincent
V
Descamps
Olivier
O
Meyer
Philippe
P
Dieudé
D000903:Antibiotics, Antineoplastic / Q000008:administration & dosage; D018906:Antineoplastic Agents, Alkylating / Q000008:administration & dosage; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use; D001859:Bone Neoplasms / Q000150:complications / Q000188:drug therapy / Q000473:pathology*; D004317:Doxorubicin / Q000008:administration & dosage; D006801:Humans; D007069:Ifosfamide / Q000008:administration & dosage; D007717:Knee / Q000473:pathology; D008279:Magnetic Resonance Imaging; D008297:Male; D020360:Neoadjuvant Therapy / Q000379:methods; D012516:Osteosarcoma / Q000150:complications / Q000188:drug therapy / Q000473:pathology*; D012878:Skin Neoplasms / Q000150:complications / Q000473:pathology*; D014983:Xeroderma Pigmentosum / Q000150:complications / Q000473:pathology*; D055815:Young Adult
D000903:Antibiotics, Antineoplastic; D018906:Antineoplastic Agents, Alkylating; D004317:Doxorubicin; D007069:Ifosfamide